Category: News

Empowering investors with access to the best research, experts and opportunities.

News

New research asserts that Prescient is deeply undervalued

Pitt Street Research has released an equity valuation report on clinical stage oncology company Prescient Therapeutics (ASX: PTX) that outlines a prosperous and swift path to market for their most advanced asset, PTX-100, while highlighting the utility of PTX’s cell therapy platforms OmniCAR and CellPryme.

Read more

Spring Racing Carnival 2023: By The Numbers

The Melbourne Spring Racing Carnival has wrapped up for another year, with four big days of punting, fabulous outfits and, most importantly, elite horse racing.

Read more

Men charged over theft of A$9m gold toilet from English palace

They thought they would be flush with cash, but they were caught with their pants down instead.

Read more

Volatility and volume drive market makers profits, which are being aggressively returned to shareholders

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In October, East 72’s Andrew Brown selected Vivendi (EPA: VIV) as one of his favourite stocks, sharing some of his thoughts on…

Read more

Note from MD: Interest rates and rare earth restrictions both rise

Another rate rise by the RBA on Melbourne Cup Day which took the cash rate target to 4.35% saw the Australian dollar and bond yields tumble. Investors were wrong-footed by the RBA’s softer-than-expected stance, as it signalled that while it would be willing to hike further if required, it is reluctant to do so unless absolutely necessary.

Read more

Pre-Christmas Retail Spending Up in 2023, Estimates Suggest

The two months leading up to Christmas are often critical for Australia’s retail sector, and this year is no different, with pre-Christmas spending in 2023 tipped to edge in line with last year’s results.

Read more

U.S. Restaurant charges extra for ‘adults unable to parent’

We’ve all seen questionably behaved kids at restaurants before, but this U.S. eatery has taken things a step further than most.

Read more

French conglomerate has a knack for acquiring, building and selling

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In October, East 72’s Andrew Brown selected Vivendi (EPA: VIV) as one of his favourite stocks, sharing some of his thoughts on…

Read more

Note from MD: Tech acquisitions fly as Fed expected to pause rates

Wall Street had a decent night in the lead up to the Fed’s interest rate decision, as some more economic data came in largely in line with expectations, spurring hope of the Fed holding its monetary policy again for the time being.

Read more

Market correction shows uncertainty in global economy

The global share markets appear to be correcting as the ASX on Monday dropped below the one-year lows briefly touched last week, closing 54.5 points, or 0.8%, lower at 6772.9.

Read more

All the different wonderful rare earth elements

In light of the strong long term outlook on rare earth elements due to their critical position in the green transition, Reach Markets have written a Rare Earths Explained review. This industry review delves into what rare earths are, where they come from, their place in net zero ambitions and geopolitics, key ESG considerations and supply/demand factors.

Read more

Prescient Therapeutics: cashed up with encouraging results flowing

Prescient Therapeutics (ASX: PTX) reported encouraging results in several key targeted and cell therapies in its September quarter activities report.

Read more

Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency

Receive the latest news and media directly to your inbox

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.